肺炎検査のグローバル市場(2022年-2029年):器具、試薬・消耗品

■ 英語タイトル:Global Pneumonia Testing Market Size study & Forecast, by Product Type (Instruments, Reagents & Consumables) by Type (Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others), by End-user (Hospitals & Clinics, Diagnostic Centers, Others) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート(データ管理コード:BZW23FE0042)■ 発行会社/調査会社:Bizwit Research & Consulting
■ 商品コード:BZW23FE0042
■ 発行日:2023年2月8日
■ 調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野:医療
■ ページ数:約200
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥752,400見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥950,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[肺炎検査のグローバル市場(2022年-2029年):器具、試薬・消耗品]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Bizwit Research社の本調査資料では、2021年にXXX億ドルであった世界の肺炎検査市場規模が、2022年〜2029年にかけてXXX%で成長すると予測しています。本資料は、肺炎検査の世界市場について市場実態を明らかにするとともに、今後の動向を展望したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析(新型コロナウイルス感染症の影響)、製品別(器具、試薬・消耗品)分析、種類別(連鎖球菌型、レジオネラ菌型、ラミドフィラ型、ウイルス性肺炎型、その他)分析、エンドユーザー別(病院・診療所、診断センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、その他)分析、競争分析、調査プロセスなどの項目で構成されています。また、主要参入企業として、Quidel Corporation (U.S.)、Abbott (U.S.)、bioMérieux SA (France)、Thermo Fisher Scientific Inc. (U.S.)、INTEC (China)、OpGen (U.S.)、Meridian Bioscience, Inc. (U.S.)、BD (Becton, Dickinson, and Company) (U.S.)、Luminex Corporation (DiaSorin S.p.A.) (U.S.)、Roche Holding AG (Switzerland)などの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析(新型コロナウイルス感染症の影響)
・世界の肺炎検査市場規模:製品別
- 器具の市場規模
- 試薬・消耗品の市場規模
・世界の肺炎検査市場規模:種類別
- 連鎖球菌型肺炎検査の市場規模
- レジオネラ菌型肺炎検査の市場規模
- ラミドフィラ型肺炎検査の市場規模
- ウイルス性肺炎検査の市場規模
- その他の市場規模
・世界の肺炎検査市場規模:エンドユーザー別
- 病院・診療所における市場規模
- 診断センターにおける市場規模
- その他における市場規模
・世界の肺炎検査市場規模:地域別
- 北米の肺炎検査市場規模
- ヨーロッパの肺炎検査市場規模
- アジア太平洋の肺炎検査市場規模
- 中南米の肺炎検査市場規模
- その他地域の肺炎検査市場規模
・競争分析
・調査プロセス

Global Pneumonia Testing Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. A lung infection known as pneumonia is caused by the bacteria, fungus, or viruses. Alveoli, the air sacs in the lungs, become inflamed and swell with fluid or pus as a result of the infection. Cough, fever, chills, and breathing difficulties are a few of the pneumonia symptoms that are frequently seen. Physical examination, evaluation of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample make the pneumonia testing process for this disease. The rise in concerns about pneumonia has led to an increase in the prevalence of the disease and early diagnosis. Also, another factor driving the growth is Increased use of point of care (POC) testing and technological advancements, such as nucleic acid detection worldwide, as well as a growth in the number of geriatric populations.

The rising prevalence of pneumonia will create the lucrative demand for the pneumonia testing market during forecast period. For instance, according to a 2019 UNICEF (United Nations International Children’s Emergency Fund) article, there are more than 1,400 cases of pneumonia per 100,000 people worldwide. Additionally, with 2,500 cases and 1,620 cases per 100,000 children, respectively, South Asia and West and Central Africa have the highest incidence of it. Therefore, the above reasons are significant growth drivers for the market. Additionally, technology advancements in pneumonia testing are one of the key aspects that are expected to fuel this growth. Higher detection efficiency is provided by the advanced multiplex PCR (mPCR) based technology for diagnosing pneumonia, which minimizes cost and time. For instance, in 2018, in the US, Curetis launched the Unyvero System and LRT Cartridge. The method utilizes powerful multiplex PCR technology to easily determine a wide range of bacteria, indicators of antibiotic resistance, or toxins from sample to response. Also, rising use of point of care (POC) testing would create the lucrative opportunity for the market during forecast period. However, the widespread utilization of chest X-rays as an essential tool for pneumonia detection stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pneumonia Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising number of pneumonia cases, favorable reimbursement policy and growing adoption of point-of-care technologies. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing geriatric population and growing cases of pneumonia would create lucrative growth prospects for the Pneumonia Testing market across Asia Pacific region.

Major market player included in this report are:
Quidel Corporation (U.S.)
Abbott (U.S.)
bioMérieux SA (France)
Thermo Fisher Scientific Inc. (U.S.)
INTEC (China)
OpGen (U.S.)
Meridian Bioscience, Inc. (U.S.)
BD (Becton, Dickinson, and Company) (U.S.)
Luminex Corporation (DiaSorin S.p.A.) (U.S.)
Roche Holding AG (Switzerland)
Recent Developments in the Market:
 September 2021: CerTest Biotec developed and tested its CE-IVD multiplex assay VIASURE M. pneumoniae, L. pneumophila and C. pneumoniae real-time PCR kit for detection of principal pathogens implicated in atypical pneumoniae.
 February 2021: Mesa Biotech, Inc. was fully acquired by Thermo Fisher Scientific Inc. The company would be able to grow its molecular diagnostics sector with the acquisition.
Global Pneumonia Testing Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Type, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Instruments
Reagents & Consumables
By Type:
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Others
By End-user:
Hospitals & Clinics
Diagnostic Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

*** レポート目次(コンテンツ)***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pneumonia Testing Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pneumonia Testing Market, by Product Type, 2019-2029 (USD Billion)
1.2.3. Pneumonia Testing Market, by Type, 2019-2029 (USD Billion)
1.2.4. Pneumonia Testing Market, by End-user, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pneumonia Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pneumonia Testing Market Dynamics
3.1. Pneumonia Testing Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Pneumonia
3.1.1.2. Technology advancements in pneumonia testing
3.1.2. Market Challenges
3.1.2.1. Utilization of chest x-rays as an essential tool for pneumonia detection
3.1.3. Market Opportunities
3.1.3.1. Rising use of point of care (poc) testing
Chapter 4. Global Pneumonia Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pneumonia Testing Market, by Product Type
6.1. Market Snapshot
6.2. Global Pneumonia Testing Market by Product Type, Performance – Potential Analysis
6.3. Global Pneumonia Testing Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
6.4. Pneumonia Testing Market, Sub Segment Analysis
6.4.1. Instruments
6.4.2. Reagents & Consumables
Chapter 7. Global Pneumonia Testing Market, by Type
7.1. Market Snapshot
7.2. Global Pneumonia Testing Market by Type, Performance – Potential Analysis
7.3. Global Pneumonia Testing Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
7.4. Pneumonia Testing Market, Sub Segment Analysis
7.4.1. Streptococcus-based
7.4.2. Legionella-based
7.4.3. Chlamydophila-based
7.4.4. Viral Pneumonia-based
7.4.5. Mycoplasma Pneumonia-based
7.4.6. Others
Chapter 8. Global Pneumonia Testing Market, by End-user
8.1. Market Snapshot
8.2. Global Pneumonia Testing Market by End-user, Performance – Potential Analysis
8.3. Global Pneumonia Testing Market Estimates & Forecasts by End-user 2019-2029 (USD Billion)
8.4. Pneumonia Testing Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Diagnostic Centers
8.4.3. Others
Chapter 9. Global Pneumonia Testing Market, Regional Analysis
9.1. Pneumonia Testing Market, Regional Market Snapshot
9.2. North America Pneumonia Testing Market
9.2.1. U.S. Pneumonia Testing Market
9.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pneumonia Testing Market
9.3. Europe Pneumonia Testing Market Snapshot
9.3.1. U.K. Pneumonia Testing Market
9.3.2. Germany Pneumonia Testing Market
9.3.3. France Pneumonia Testing Market
9.3.4. Spain Pneumonia Testing Market
9.3.5. Italy Pneumonia Testing Market
9.3.6. Rest of Europe Pneumonia Testing Market
9.4. Asia-Pacific Pneumonia Testing Market Snapshot
9.4.1. China Pneumonia Testing Market
9.4.2. India Pneumonia Testing Market
9.4.3. Japan Pneumonia Testing Market
9.4.4. Australia Pneumonia Testing Market
9.4.5. South Korea Pneumonia Testing Market
9.4.6. Rest of Asia Pacific Pneumonia Testing Market
9.5. Latin America Pneumonia Testing Market Snapshot
9.5.1. Brazil Pneumonia Testing Market
9.5.2. Mexico Pneumonia Testing Market
9.5.3. Rest of Latin America Pneumonia Testing Market
9.6. Rest of The World Pneumonia Testing Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Quidel Corporation (U.S.)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott (U.S.)
10.2.3. bioMérieux SA (France)
10.2.4. Thermo Fisher Scientific Inc. (U.S.)
10.2.5. INTEC (China)
10.2.6. OpGen (U.S.)
10.2.7. Meridian Bioscience, Inc. (U.S.)
10.2.8. BD (Becton, Dickinson, and Company) (U.S.)
10.2.9. Luminex Corporation (DiaSorin S.p.A.) (U.S.)
10.2.10. Roche Holding AG (Switzerland)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. Global Pneumonia Testing Market, report scope
TABLE 2. Global Pneumonia Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Pneumonia Testing Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
TABLE 4. Global Pneumonia Testing Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 5. Global Pneumonia Testing Market estimates & forecasts by End-user 2019-2029 (USD Billion)
TABLE 6. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Pneumonia Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Pneumonia Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Pneumonia Testing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Pneumonia Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Pneumonia Testing Market
TABLE 71. List of primary sources, used in the study of global Pneumonia Testing Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BZW23FE0042 )"肺炎検査のグローバル市場(2022年-2029年):器具、試薬・消耗品" (英文:Global Pneumonia Testing Market Size study & Forecast, by Product Type (Instruments, Reagents & Consumables) by Type (Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others), by End-user (Hospitals & Clinics, Diagnostic Centers, Others) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。